Page last updated: 2024-09-03

gr 73632 and oxazoles

gr 73632 has been researched along with oxazoles in 1 studies

Compound Research Comparison

Studies (gr 73632)	Trials (gr 73632)	Recent Studies (post-2010) (gr 73632)	Studies (oxazoles)	Trials (oxazoles)	Recent Studies (post-2010) (oxazoles)
77	1	9	9,281	366	2,561

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ball, RG; Bao, J; Bunda, J; Chicchi, G; Cook, J; DeVita, RJ; Doss, GA; Eng, W; Gantert, L; Hargreaves, R; Hora, DF; Jiang, J; Karanam, B; Kassick, AJ; Kumar, S; Lin, P; Lu, H; Madeira, M; Mills, SG; Purcell, M; Samuel, K; Tong, X; Tsao, KL; Tschirret-Guth, R; Wang, H; Wilson, D	1

Other Studies

1 other study(ies) available for gr 73632 and oxazoles

Article	Year
2-[(3aR,4R,5S,7aS)-5-{(1S)-1-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2H-isoindol-2-yl]-1,3-oxazol-4(5H)-one: a potent human NK1 receptor antagonist with multiple clearance pathways. Journal of medicinal chemistry, 2013, Jul-25, Volume: 56, Issue:14 Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Glucuronides; Humans; Isoindoles; Metabolic Clearance Rate; Neurokinin-1 Receptor Antagonists; Oxazoles; Peptide Fragments; Substance P	2013

Article

Year

2-[(3aR,4R,5S,7aS)-5-{(1S)-1-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2H-isoindol-2-yl]-1,3-oxazol-4(5H)-one: a potent human NK1 receptor antagonist with multiple clearance pathways.

Journal of medicinal chemistry, 2013, Jul-25, Volume: 56, Issue:14

Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Glucuronides; Humans; Isoindoles; Metabolic Clearance Rate; Neurokinin-1 Receptor Antagonists; Oxazoles; Peptide Fragments; Substance P

2013